The Effect of Chinese Medicine on Lipid and Glucose Metabolism in Acute Myocardial Infarction Through PPARγ Pathway

Aim: Danqi Pill (DQP), a Chinese medicine frequently prescribed in China, has been approved to improve cardiac function by regulating cardiac energy metabolism in heart failure (HF) after acute myocardial infarction (AMI) patients. The aim of this study was to explore whether the mechanism of DQP is...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qian, Shao, Mingyan, Zhang, Xuefeng, Wang, Qiyan, Guo, Dongqing, Yang, Xiaomin, Li, Chun, Wang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207917/
https://www.ncbi.nlm.nih.gov/pubmed/30405421
http://dx.doi.org/10.3389/fphar.2018.01209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6207917/
https://www.ncbi.nlm.nih.gov/pubmed/30405421
http://dx.doi.org/10.3389/fphar.2018.01209

Ejemplares similares